Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lubman Ellen
Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Trost Timothy W.
Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Isaacs Randi
Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Karunatilake Chulani
Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HICKLIN DANIEL J
Werewolf Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PFM Health Sciences, LP(7.8%),PFM Health Sciences GP, LLC(7.8%), etc.
Werewolf Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BANK OF AMERICA CORP /DE/(4.9%)
Werewolf Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(3.05%),David Rosen(3.05%)
Werewolf Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Management, L.P.(4.58%),Robert Atchinson(4.58%), etc.
Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DiRocco Derek
Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Morrison Briggs
Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Atkins Michael B.
Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chatterjee Meeta
Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sherman Michael A.
Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director EVNIN LUKE
Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lazarus Alon
Werewolf Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(14.2%),Peter Kolchinsky(14.2%), etc.
Werewolf Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(15.2%),Peter Kolchinsky(15.2%), etc.
Werewolf Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PFM Health Sciences, LP(9.6%),PFM Health Sciences GP, LLC(9.6%), etc.
Unlock the Full List